8 news items
Elicio Therapeutics Unveils Promising Phase 1a Data For ELI-002 7P In mKRAS Tumors
ELTX
10 Jun 24
company focused on developing innovative lymph node-targeted immunotherapies to treat aggressive cancers. Given the firm's expertise in materials
Elicio Therapeutics Announces Preliminary Data from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting
ELTX
23 May 24
be guaranteed, and actual results may differ materially from those projected. Elicio undertakes no obligation to publicly update any forward-looking
Elicio Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Updates
ELTX
15 May 24
differ materially from those projected. Elicio undertakes no obligation to publicly update any forward-looking statement, whether as a result of new
Elicio Therapeutics to Present New Preliminary Data from the Ongoing AMPLIFY-7P Phase 1/2 Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting
ELTX
25 Apr 24
not to place undue reliance on them. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. Elicio
Elicio Therapeutics (NASDAQ: ELTX) Makes Strides In Growing Cancer Vaccination Industry
ELTX
11 Apr 24
in the development of cancer immunotherapies for patients facing limited treatment options and often poor outcomes. The platform combines expertise in materials
hsbe7jmyn0jez4ay4k6wj7efiof33wwiwcdxugko2
ELTX
5 Apr 24
differ materially from those projected. Elicio undertakes no obligation to publicly update any forward-looking statement, whether as a result of new
3jf5q9wcaj29elzs58ifv
ELTX
5 Apr 24
. Developed at the Massachusetts Institute of Technology (MIT), the company's proprietary Amphiphile or "AMP" platform, which combines expertise in materials
jlbotkot
ELTX
5 Apr 24
. Developed at the Massachusetts Institute of Technology (MIT), the company's proprietary Amphiphile or "AMP" platform, which combines expertise in materials
- Prev
- 1
- Next